THE APEX TIMES
AI selloff cools, and chip rebounds carry Monday’s market back toward risk appetite
Broadcom, Corning, Micron and Eli Lilly were among the biggest movers as investors weighed whether Friday’s slide was a reset or the start of a deeper pullback.
U.S. stocks moved higher on Monday, June 8, 2026, after Friday’s sharp selloff in AI-linked equities left many chip and infrastructure names trading at low levels for the start of the week. Reuters reported that S&P 500 and Nasdaq 100 e-minis climbed in early trading as chip stocks “steadied” after dropping to over two-week lows, while renewed strikes in the Middle East kept investors cautious. The rebound helped shift focus from price momentum toward near-term catalysts across semiconductors, data center supply chains and even pharmaceuticals.
The broader selloff that preceded Monday’s bounce was linked to worries about whether expectations for AI growth had become too aggressive. In a Reuters report on Friday, U.S.-listed chipmakers lost more than $1 trillion in market value, with the PHLX semiconductor index down almost 8.5% in afternoon trading. Reuters also tied the shock to weak demand indicates after Broadcom posted results earlier in the week that showed demand for its custom AI chips business falling short of lofty expectations. Broadcom fell 7.5% on Friday, and Nvidia, Micron Technology and AMD posted steep declines as well.
On Monday, chip stocks largely reversed course in premarket trading, according to Reuters. Shares of Nvidia, Broadcom and Micron Technology rose between 1.5% and 3.9% before the open, rebounding from Friday’s drop. Reuters said expectations of tighter monetary policy and “underwhelming results from Broadcom last week” had raised concerns that the sector was growing too fast, prompting traders to pull back after a strong run in 2026. Strategists at UBS Global Wealth Management were quoted emphasizing that investors did not expect a loss of confidence in the AI outlook even as tech expectations faced scrutiny.
The rebound also reflected company-specific drivers outside pure AI-chip demand. An AP report said Micron Technology rose sharply on Monday after sliding 13.3% on Friday, and Marvell Technology climbed following its first trading day after S&P Dow Jones Indices said it had gained enough to join the widely followed S&P 500. AP characterized the broader theme as a market trying to determine whether Friday’s drop marked the beginning of a downturn or a pause that shakes out excessive optimism, with price action in chip and memory stocks acting as the clearest barometer.
Corning, a supplier of optical components used in high-capacity communications, gained ground on Monday after news tied it more directly to data center buildouts. AP reported Corning climbed 6.2% after Amazon announced a multibillion-dollar deal in which Corning will produce optical fiber, cable and other products for Amazon data centers across the United States. For investors, the move suggested incremental confidence that the optical and connectivity supply chain remains a beneficiary of AI infrastructure spending even as parts of the semiconductor market cool.
Eli Lilly was the outlier on the day’s “stocks explaining the tape” list, rising on a development unrelated to semiconductors. Reuters said Eli Lilly shares jumped 4.1% after trial results for retatrutide, an investigational next-generation obesity drug, showed improvements beyond weight loss. Reuters reported the study found retatrutide helped curb sleep apnea severity and also eased knee pain, at least in the reported trial outcomes. The reaction underscored how, when markets de-risk, investors often look for narrative support from major clinical data as well as from AI-adjacent industrial demand.
Broadcom entered Monday’s trading with extra sensitivity to expectations, even beyond market-wide rate worries. Broadcom describes itself as a global technology company that designs and supplies semiconductor and infrastructure software solutions, with products spanning networking, broadband, cybersecurity and private and hybrid cloud infrastructure. In the Reuters reporting on Friday’s selloff, the key concern was not the company’s long-term position in AI infrastructure, but the near-term demand announcement reflected in its custom AI chips performance. What remained unclear from the reports was the magnitude and breakdown of the shortfall, as well as whether any incremental demand visibility was provided after Friday’s close. The next test for the market, according to Reuters, was Wednesday’s consumer price report for May, which could further influence expectations for Federal Reserve policy.
keyFacts
Why It Matters
- The rebound suggests investors were willing to buy back into parts of the AI supply chain after a sentiment reset, but it also highlights how fragile positioning can be when expectations get recalibrated.
- Broadcom remains a sentiment bellwether for AI infrastructure demand, even as it is not a pure “chip maker” in the classic sense, because its mix includes semiconductors and infrastructure software.
- Corning’s jump points to continued market focus on data center connectivity, even when investors question the pace of AI-chip growth.
- Eli Lilly’s move shows how, in a choppy tape, investors can rotate to major clinical catalysts outside tech when they seek reassurance.
Sources
Key Facts
- Friday’s chip selloff wiped out more than $1 trillion in market value for U.S.-traded chipmakers, according to Reuters.
- The PHLX semiconductor index fell almost 8.5% on Friday, with Broadcom, Nvidia, Micron Technology and AMD among the major decliners, Reuters reported.
- Reuters said Friday’s drop was amplified by a weak Broadcom report earlier in the week showing demand for its custom AI chips business falling short of expectations.
- On Monday premarket, Reuters reported Nvidia, Broadcom and Micron shares rose between 1.5% and 3.9%.
- AP reported Corning gained 6.2% after Amazon announced a multibillion-dollar deal for Corning to supply optical fiber, cable and related products for U.S. data centers.
- Reuters reported Eli Lilly rose 4.1% after trial results for retatrutide showed improvements in sleep apnea severity and weight loss, and easing of knee pain.
Technology Related
Jim Cramer tells viewers Starbucks can grow without expanding data-center exposure, Apple’s audience is ‘worth paying for,’ and Intel shareholders should stay patient
In remarks carried by Yahoo Finance, Jim Cramer argued that Starbucks’ valuation does not rely on building large computing infrastructure, Apple’s customer base has durable economics, and Intel investors may need to look beyond near-term uncertainty.
Dow posts best session in more than a month as hotter producer prices cool AI-spending hopes; Meta among names in focus
U.S. producer prices rose 6.3% in September, the fastest pace since 2022, adding to investor worries about overspending on artificial intelligence and stretching valuations. Equity trading showed a rotation away from AI-linked “growth at any price” expectations, with the Dow’s strongest day in over a month.
Meta rolls out new ad tools aimed at boosting campaign visibility across Facebook and Instagram
At a brand-building summit, the company announced a set of upgrades to how advertisers can structure campaigns, including a new “First Impressions” option and expanded Reels ad services.
Netflix faces renewed scrutiny as analysts question whether subscriber retention is weakening
A market report flagged concerns that rising churn and softer viewer engagement could make it harder for Netflix to keep subscribers, as competition in streaming intensifies.
Arista Networks emerges as the quiet “AI networking” alternative as data-center demand rises
A market focus on GPUs and big switch makers is leaving space for Arista Networks, whose shares have outperformed both Nvidia and Cisco this year, according to a recent market roundup.
Dow Jones futures slipped as Disney and Salesforce shares led a rebound; Tesla’s Roadster remained a market talking point
U.S. stock index futures pointed lower after a volatile session, while traders leaned into select consumer and software names, including Salesforce, and pulled some AI-related stocks off their lows.
iPhone Duo Preorders Set to Start Friday, Stirring Fresh Questions About Apple’s Next-Phase Hardware Push
A new report says Apple’s first foldable phone, dubbed iPhone Duo, is slated to enter preorders this week, renewing debate over whether a single device can move the stock, or whether investors should look at Apple’s broader platform strategy.
IonQ leans into a broader “quantum ecosystem” strategy, drawing comparisons to Nvidia’s platform playbook
A recent market analysis argues IonQ is trying to capture more of the quantum computing value chain, even after a sharp share-price pullback.
Palantir moves AI onboarding into commercial banking with Customers Bank deal
Palantir says it will deploy Foundry and AIP to help Customers Bank automate commercial client onboarding workflows, aiming to reduce manual steps and speed up how information is gathered and processed.
AI shopping bots raise new questions for Amazon as Elon Musk outlines interest in an Amazon rival
A Yahoo Finance report says Grok bot users claim Amazon blocked them from placing orders, and argues that the episode could create opening space for a new competitor. Amazon has not publicly detailed any policy on AI agents in the episode described.